Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
DARVON-N |
| Manufacturer |
|
Xanodyne Pharmacal, Inc. |
| Legal Classification |
|
CIV |
| Pharmacological Class |
|
Opioid. |
| Generic Name |
|
Propoxyphene napsylate 100mg; tabs. |
| Also |
|
• DARVON
|
| Indications |
|
Mild to moderate pain. |
| Children |
|
Not recommended. |
| Adults |
|
100mg every 4 hours as needed; max 600mg daily. |
| Contraindications |
|
Suicidal or addiction-prone patients. |
| Precautions |
|
Impaired renal or hepatic function. Elderly. Debilitated. Pregnancy. Nursing mothers. |
| Interactions |
|
Potentiation with alcohol, CNS depressants. May increase levels of antidepressants, anticonvulsants, coumarin anticoagulants, others. Coma, severe neurological effects seen with carbamazepine. |
| Adverse Reactions |
|
Dizziness, sedation, nausea, vomiting, constipation, rash; respiratory depression (overdosage). |
| How Supplied |
|
Tabs, caps—100, 500 |
|
|
|
|
